SSG
AUXL

Summit Securities Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Summit Securities Group’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,717
Closed -$104K – 649
2013
Q3 		$104K Buy
+5,717
New +$103K 0.04% 156

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Securities Group's AUXL Position: Q4 2013 in Review

Summit Securities Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2013, closing a stake of 5,717 shares — an estimated $104K sold.

Summit Securities Group first reported a position in AUXL in Q3 2013 and held it in 1 quarter. The position peaked at $104K in Q3 2013. 147 funds tracked by Wall St. Rank hold AUXL as of Q4 2013.

  • Summit Securities Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Summit Securities Group sold 5,717 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2013, an estimated $104K.
  • Summit Securities Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Summit Securities Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $104K in Q3 2013.
  • 147 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2013.

Based on Summit Securities Group's 13F filing for Q4 2013, filed 13 Feb 2014.